Legal cannabis scored another big victory this week.
In April, Mexico’s lower parliament overwhelmingly voted to legalize medical cannabis, voting 357 to 7.
Then, earlier this week, Mexico’s President Enrique Pena Nieto signed the bill into law, legalizing the use of medicinal cannabis THC, CBD, and all cannabis derivatives. The new legislation also makes it legal to produce and distribute cannabis for medical and therapeutic purposes.
Early estimates project sales between $1 billion and $2 billion in the first 10 years. That would come out to between $100 and $200 million per year. Continue “Mexico’s Big Cannabis News – What it means for MJNA”
In the old days, pot was seen as a way to get stoned.
But now, researchers are discovering that pot can actually have many health benefits.
Most of those come from Cannabidiol – one of the most prevalent compounds found in hemp plants that is commonly refereed to as CBD on the Street.
Studies have shown that the non-psychoactive elements of CBD can deliver relief to a wide range of ailments, including aches, pains, anxiety, insomnia and arthritis – without the euphoric effects provided by THC.
Continue “Secret CBD Company Grows Sales 1,300% in 12 Months”
Blockbuster drugs are the holy grail of the pharmaceutical and biotech industry.
When annual sales of a new drug break the $1 billion mark, investors are usually rewarded with big gains.
This is what began happening late 2012 with Gilead Science (Nasdaq: GILD).
In 2013 the FDA approved Gilead’s hepatitis C drug Sovaldi.
Then, in 2014, Gilead scored an FDA approval for another Hep C drug, Harvoni. Continue “A 2nd Cannabis Stock with $1 Billion Drug Potential”
